Sign in

CIK 0001274737

  • Non-accelerated filer
  • Smaller reporting company

EXAGEN INC.

Sign in to watch
Ticker
XGN
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 760-560-1501
Business address
1261 LIBERTY WAY, VISTA, CA, 92081
Former names
EXAGEN DIAGNOSTICS INC
  1. 4 Open-market sale Chief Financial Officer sold 1,584 shares at $3.61 ($5,718)
  2. 4 Open-market sale President and CEO sold 31,787 shares at $11.82 ($375,598)
  3. 4 Open-market sale Chief Financial Officer sold 20,466 shares at $9.79 ($200,362)
  4. 4/A Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale 10% owner sold 350,000 shares at $3.30 ($1,155,000)
  11. 4 Grant or award President and CEO acquired 8,621 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 112,500 shares (grant or award)
  14. 4/A Insider Changes in Ownership
  15. 4 Open-market sale 10% owner sold 200,000 shares at $3.30 ($660,040)
  16. 4 Open-market buy Chief Financial Officer bought 22,298 shares at $2.98 ($66,448)
  17. 4 Open-market buy President and CEO bought 24,305 shares at $2.81 ($68,297)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Chief Financial Officer acquired 225,000 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 2 of 9 · 168 filings